Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Grant/Award of 7,000 KYNB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | KYNTRA BIO, INC. (KYNB) | Grant/Award | 7,000 | n/a |
| Apr 23, 2026 | BIO-RAD LABORATORIES, INC. | Exercise/Conversion | 407 | n/a |
| Jun 6, 2025 | FIBROGEN INC (FGEN) | Grant/Award | 120,000 | n/a |
| Apr 24, 2025 | BIO-RAD LABORATORIES, INC. | Exercise/Conversion | 308 | n/a |
| Sep 10, 2024 | BIO-RAD LABORATORIES, INC. | Grant/Award | 308 | n/a |
| Jul 10, 2024 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Grant/Award | 30,000 | n/a |
| Jun 21, 2024 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 45,000 | n/a |
| Jun 7, 2024 | FIBROGEN INC (FGEN) | Grant/Award | 70,000 | n/a |
| Feb 2, 2024 | LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) | Exercise/Conversion | 9,554 | n/a |
| Jun 23, 2023 | Clearside Biomedical, Inc. (CLSD) | Grant/Award | 30,000 | n/a |